Patents by Inventor Jason C. Rouse

Jason C. Rouse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210106658
    Abstract: Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
    Type: Application
    Filed: May 25, 2020
    Publication date: April 15, 2021
    Inventors: KEITH A. JOHNSON, JASON C. ROUSE, PENELOPE JANE SHARPE, MICHAEL SHAMASHKIN, WENDY CAROL PIACENZA, MARY BETH SWITZER, STACEY B. WESTON, Michael Anthony JANKOWSKI
  • Patent number: 10660946
    Abstract: Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: May 26, 2020
    Assignee: Pfizer Inc.
    Inventors: Keith A. Johnson, Jason C. Rouse, Penelope Jane Sharpe, Michael Shamashkin, Wendy Carol Piacenza, Mary Beth Switzer, Stacey B. Weston, Michael Anthony Jankowski
  • Publication number: 20170333535
    Abstract: Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
    Type: Application
    Filed: August 4, 2017
    Publication date: November 23, 2017
    Inventors: KEITH A. JOHNSON, JASON C. ROUSE, PENELOPE JANE SHARPE, MICHAEL SHAMASHKIN, WENDY CAROL PIACENZA, MARY BETH SWITZER, STACEY B. WESTON, Michael Anthony JANKOWSKI
  • Patent number: 9757434
    Abstract: Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: September 12, 2017
    Assignee: PFIZER INC.
    Inventors: Keith A. Johnson, Jason C. Rouse, Penelope Jane Sharpe, Stacey B. Weston, Michael Anthony Jankowski
  • Publication number: 20150182604
    Abstract: Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
    Type: Application
    Filed: September 24, 2014
    Publication date: July 2, 2015
    Inventors: KEITH A. JOHNSON, JASON C. ROUSE, PENELOPE JANE SHARPE, MICHAEL SHAMASHKIN, WENDY CAROL PIACENZA, MARY BETH SWITZER, STACEY B. WESTON, Michael Anthony JANKOWSKI
  • Publication number: 20080118932
    Abstract: The invention relates to methods for analyzing glycomolecules such as glycoproteins, and glycan structures associated with preparations of such glycomolecules.
    Type: Application
    Filed: November 9, 2007
    Publication date: May 22, 2008
    Inventors: Kelly N. Toler, Tanya Q. Shang, Thomas J. Porter, Jason C. Rouse
  • Patent number: 7108150
    Abstract: A tubular member is releasably mounted on a base and encircles a trash bag that rests on the base. Once the trash bag is filled, the tubular member is released from the base and removed from the filled trash bag. The filled trash bag can then be removed and discarded.
    Type: Grant
    Filed: January 14, 2005
    Date of Patent: September 19, 2006
    Inventors: Jason C. Rouse, Lindsey Jo Rouse